Spread and Potential Risks of Genetically Modified Organisms  by Arcieri, Margherita
 Agriculture and Agricultural Science Procedia  8 ( 2016 )  552 – 559 
2210-7843 © 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Peer-review under responsibility of Fondazione Simone Cesaretti
doi: 10.1016/j.aaspro.2016.02.072 
Available online at www.sciencedirect.com
ScienceDirect
Florence “Sustainability of Well-Being International Forum”. 2015: Food for Sustainability and 
not just food, FlorenceSWIF2015 
Spread and Potential Risks of Genetically Modified Organisms 
Margherita Arcieri* 
PhD in Environmental and Agri-Food Economics 
University of Pathenope (Naples) 
Abstract 
Genetic engineering is a technique that allows to detect, isolate, multiply and transplant specific genes in another living organism. 
The introduction of genes in another living organism or other species is a process unstable and insecure with side effects and 
consequences difficult to predict on the recipient genome and interaction with the surrounding environment. 
The main proponent are big business owners of patents in the field of GMOs and other stakeholders, including some GMO 
growers and scientists, as well as international trading partners. 
The potential economic interests in relation to GMOs in the field of plant breeding are considerable, the world annual turnover of 
the seed market has now exceeded 35 billion Euros. Today the world market is dominated by only a handful of large operators. 
The same multinational companies operating in the food, plant protection chemicals, energy and pharmaceutical industries. This 
concentration allows a small group of corporations to exercise considerable control over the entire production chain of food and 
related products, thus putting at risk the freedom of choice, the accessibility of prices, open innovation and diversity genetics. 
The development and dissemination of GMOs through these centuries-old-traditions have been called the Green Revolution. The 
greater use of chemicals in agriculture offers the possibility of a higher gain, but requires a greater dose of herbicides over time, 
which makes it necessary to look for a more aggressive chemical solution.  
However, on the basis of objective evidence one can conclude that genetic engineering is not  fundamentally new to these 
historical applications. The advent of genetic engineering marks a definitive break between the biotechnology of "old" and the 
“modern” conception. 
Among the arguments used more frequently to support the use of GMOs, is the need to fight hunger, to ensure the supply of food 
to a growing world population and the fight against climate change. The majority of genetically modified varieties currently on 
the market are grown for forage and feed for livestock, for meat and milk consumed in the Western World, or to produce biofuel 
or plastics. 
The increase in non-food use of edible agricultural products has pushed-up the prices of raw materials and foodstuffs on the 
world market, which has done nothing but exacerbate food insecurity and poverty in the world. The problems of the global food 
supply difficulties arise not so much from production to distribution since global production is equivalent to over 150% of global 
consumption. Consequently this requires a political and economic solution rather than agricultural innovation. 
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1. Introducttion 
The discussion of genetically modified organisms (GMOs) is a delicate one. Genetic engineering arouses great 
interest but also deep concern. The debate is often emotional and polarized, and when it is rational, both proponents 
and opponents tend to interpret reality in a selective manner, paying little attention to the nuances. Moreover, 
beyond the differences of opinion on the advantages and disadvantages of genetic engineering, even within the 
European Economic and Social Committee (EESC) there are many uncertainties and assumptions regarding, among 
other things, the nature and extent of legal regulation of GMOs in the EU. Because it is such an important issue, it 
deserves and should demand a politically sensitive discussion. As the current EU legal framework on GMOs is 
being edited, it is foreseen that the Committee will formulate more different opinions on policy and legislation 
regarding GMOs. 
In this analysis several aspects are relevant, such as ethical, ecological, technological, socio- economic, legal and 
political. All of the questions that are raised by genetic engineering and the rapid development of applications 
related to GMOs should be examined in a broad social context. 
2. History 
Genetic engineering gives rise to differing opinions even about its history. While critics talk about a 
fundamentally new technology, involving certain risks and raising ethical reservations, proponents of genetic 
engineering point to historical traditions in the field of plant breeding and biological treatment processes using 
yeasts, bacteria and fungi (Mazoyer and Roudart, 2006). 
The development and dissemination of GMOs through these centuries-old-traditions have been called the Green 
Revolution. The greater use of chemicals in agriculture offers the possibility of a higher gain, but requires a greater 
dose of herbicides over time, which makes it necessary to look for a more aggressive chemical solution (Saltini, 
2003; Capocci, 2008). 
However, on the basis of objective evidence one can conclude that genetic engineering is not  fundamentally new 
to these historical applications. The advent of genetic engineering marks a definitive break between the 
biotechnology of "old" and the “modern” conception (Prentis, 1984). With the discovery in 1953 by Watson and 
Crick's double helix structure of DNA revealing the genetic code of humans and all the flora and fauna around us, it 
enabled scientists to perform manipulations in revolutionary level of genes, ie the ' building blocks' of life (Caprioli, 
2003). 
Genetic engineering made its appearance in 1973, when some U.S. scientists successfully carried out the first 
experiments on bacteria using recombinant DNA fragments. The ability to detect, isolate, multiply, and transplant 
specific genes in another living organism has enabled scientists to achieve results that are impossible to obtain in 
nature through play and/or natural recombinations (Lewontin, 2002). Prior to that, classical hybridization methods 
were combined with genomes (similar species) with an attempt to preserve the positive characteristics through the 
redial. Although genetic engineering allowed for more precise manipulation, the introduction of genes into another 
organism (or other species) is a process unstable and insecure, with side effects and consequences difficult to predict 
on the recipient genome and interactions with the surrounding environment. The long-term effects, in particular, are 
still largely unknown, for the first time, to change specifically inherited genetic characteristics of living organisms 
(Centini, 1999). 
After 1975, with the development of genetic engineering, there was a significant acceleration. The first products 
(drugs) genetically modified were already marketed in 1982 and in the early '90s following plants and transgenic 
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animals (Cavalli-Sforza, 1995). Over the years  the boundary between the species is broken and new varieties are 
introduced, for example, a gene of the pig in a tomato, a firefly gene into a tobacco plant and a human gene into a 
bull. The killing of the natural boundaries between species, the unpredictability of long-term effects and 
irreversibility of the potential environmental consequences  are among the main risks associated with GMO (Rifkin, 
2003; Lezzi, 2003). 
It is therefore important that the legislation on GMOs in the EU and its Member States, in many third countries 
and in international treaties be based on this reality. 
3. Risks and benefits 
Not all of these areas of genetic engineering are the subject of heated debate in the same way. The concerns and 
reservations of the political and public opinion seem to be due not so much to genetic engineering as such, but rather 
to certain applications: in general, the medical applications are welcomed (Sgreccia, 2007), while the tones make the 
comparison especially fierce when the latter focuses on the agricultural and food sectors. A central element of the 
debate is the weighing between the utility and the need, on the one hand, and the possible risks and reserves on the 
other (Caprioli, 2003).  
Science and other prestigious journals such as “British Medical Journal”, “Lancet”, and “Nature” have 
contributed to this broad debate , which was vigorous in 1999, particularly as a result of the stir caused by Arpad 
Pusztai’s premature release of information to the popular media, before publication in the scientific press, about 
adverse effects in rats that ate GM potatoes. In the early months of 2000, however, the concern about the health risks 
of the transgenic foods seems relatively latent (Ewen and Pusztai, 1999). 
Many citizens consider, for example, that genetic engineering provides an important and promising contribution 
to the treatment of serious human diseases, and in the food industry the benefits of GMOs (the current generation) to 
consumers are much less evident (for the moment, in fact, they consist purely agronomic characteristics, 
advantageous for producers). Moreover, the rules of safety and clinical trials prior to granting authorization for 
medical applications have always been much more rigorous and extensive than the procedures necessary for the 
introduction of GMOs into the environment or in food (Kolata, 1998). 
According to the information reported by the WHO (World Health Organization), the genetically modified 
products, that are currently on the international market, have all passed risk assessments conducted by national 
authorities. These assessments have not indicated any risk to human health. In spite of this, it is interesting to note 
that the review articles published in international scientific journals during the current decade did not find, or the 
number was particularly small, references concerning human and animal toxicological/health risks studies on GM 
foods (Domingo, 2000). 
Moreover, from a social point of view, it is important to make a distinction between application of genetic 
engineering that takes place in a closed and isolated environment and applications that are released into the 
environment, without the possibility of containment.  
A closed and isolated environment consist of laboratories, factories and greenhouses, consisting of conditions 
with effective containment and adequate security measures to prevent accidental leakage of GMOs. 
Genetically modified plants or animals, are able to reproduce, spread and propagate in an uncontrolled and 
irreversible biosphere, with unpredictable effects on the surrounding biodiversity and interactions with the latter 
(Greenpeace, 2013). 
The genetically modified enzymes are also used on a large scale in food production in isolated environments, 
without being present in the form of living organisms in the final product, potentially ending up in the external 
environment. The distinction between use in a confined space entry and in the open field, as well as between basic 
scientific research and commercial applications, are two important elements of the political debate on GMOs, their 
perception by the public and the reaction of consumers to these substances (FAO, 1999). 
As shown consistently by numerous surveys, in particular “Eurobarometer”, as well as from academic literature, 
the majority of the EU population is growing very skeptical, regards to GMOs, particularly in food, feed and 
agriculture. Even in the governments of the Member States there are opinions and divergent policies on GMOs.  
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Opponents that are convinced  such as Austria, Hungary, Italy, Greece, Poland and Latvia, lined up supporters from 
the  Netherlands, the United Kingdom, Sweden, Spain, Portugal and the Czech Republic, while many other Member 
States shall refrain from taking a stand (De Acetis, 2004). 
Several civil society organizations and stakeholders have expressed reservations about genetic engineering in 
relation to the environment, animal welfare, consumer protection, agriculture, beekeeping, rural development and 
global ethics, religion. In several instances there has been critique toward GMOs and their disciplines by the 
European Parliament as well as the Committee, various national authorities, regional and local authorities and 
independent scientists. The main proponents are big business owners of patents in the field of GMOs and other 
stakeholders, including some GMO growers and scientists, as well as international trading partners with strong 
economic interests for a more flexible regulation of this matter in the EU. 
The political and social resistance towards GMOs in food and environment are also found outside the EU, 
especially in countries such as Japan, South Korea, New Zealand, Mexico, the Philippines and several African 
states. However, there are countries where the species GMOs are cultivated on a large scale. For example, in 2010, 
the varieties of genetically modified soy, corn and cotton were seeded over 15 million farmers over an area of about 
150 million hectares. It should be noted, however, that 90% of these acres were concentrated in just five countries: 
United States, Canada, Argentina, Brazil and India (European Commission, 2000). Yet, despite this large-scale use, 
even in this group of countries, the issue of GMOs is controversial: in fact, recent criticism seems to be increasingly 
raised by the traditional farmers, mainly because of incidents involving unintentional dissemination of varieties of 
genetically modified crops such as corn and rice, and judicial decisions in the field of coexistence. It should be noted 
that in these countries there is no labelling requirement, which means that consumers are not aware of the presence 
of GMOs in products and therefore can not make an informed choice (Bruening and Lyons, 2000). 
4. Economic interests, intellectual property and focus of the market 
The potential economic interests in relation to GMOs in the field of plant breeding are considerable. The world 
annual turnover of the seed market has now exceeded € 35 billion and is the basis of a market for the products even 
more, with a potential of several hundred billion Euros (James, 1998). 
Genetic engineering and marketing of GM products have experienced an extraordinary development, which has 
greatly affected the environment in which businesses operate in this sector. The protection of intellectual property in 
the field of plant breeding is insured for over half a century by the law of “plant variety”, enshrined in various 
international agreements (Rifkin, 2003). 
Other breeders can freely use the protected variety without the need for authorization from the original breeder, 
in order to develop new best choice. 
This exemption, which does not exist in any other sector, is dictated by the realization that new varieties can not 
be created from nothing (AceA, 2000). 
 Developments in molecular biology, which was born outside of agriculture, have led to the introduction of right 
patent in the field of the plants selection. Patent law and the right to plant variety are, for various reasons, in conflict 
with each other. The former, in fact, does not provide for any exemption in favor of breeders: the patentee may, in 
fact, claim an exclusive right to the genetic material and ban the use of other or impose costly licenses (Venturini, 
2008). Unlike  property rights, patent right is not conducive to open innovation that allows one to combine economic 
incentives for innovation by protecting other public interests. 
 The dispute over the rights goes further. The European Directive on the patentability of biotechnological 
inventions logic adopted in 1998 allows for the patent protection of inventions related to plants. Unlike the plants,  
genes or sequences of plant genes can then be patented, this interpretation has not reached consensus. Some 
multinational leaders in the field of plant breeding believe that the genetic characteristics are patentable, and also 
consider the variety being subject to the patent right. In this case, the varieties covered by patent can no longer be 
used by others for the purpose of further innovation, leading to negative effects on agricultural biodiversity. 
Developments in medical biotechnology emphasize the negative consequences that may result from this 
interpretation: the strict protection afforded by patents and high prices mean that new products can be purchased 
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only by persons who have the means to do so and are inaccessible to the disadvantaged. The same undesirable 
consequences may occur in the field of plant breeding (Capretti, 2000). 
5.The world market 
In recent decades, this sector has seen an enormous concentration of the market, mainly due to the patent 
protection and regulatory requirements. While in the past hundreds of companies were operating in this area, today 
the world market is dominated by only a handful of large operators. In 2009, almost 80% of the world seed market 
was controlled by just ten companies, the first three of which were divided by as much as 50%. The same 
multinationals also controlled 75% of the global agrochemical industry. It is no longer compromised only of firms 
specialized in the genetic improvement of plants, but also large multinational companies operating in the food, plant 
protection chemicals, energy and pharmaceutical industry (Rifkin, 2003). They also often produce complementary 
products such as genetically modified plants made resistant to a particular pesticide marketed by the same company. 
This concentration allows a small group of corporations to exercise considerable control over the entire production 
chain of food and related products, thus putting at risk the freedom of choice, the accessibility of prices, open 
innovation and genetics diversity. A similar degree of market concentration and monopoly, undesirable in any case 
especially in key sectors such as agriculture and food supply, deserves priority attention by the EESC and the EU. 
Among the arguments used more frequently to support the use of GMOs, is the need to fight hunger, to ensure 
the supply of food to a growing world population and the fight against climate change (Bonny, 1998). In all these 
fields, there is a great need for independent scientific research, and the EESC stresses the importance of ensuring 
structural constant funding from the EU in these activities, not only to promote scientific innovation and business, 
but also to study the socio-economic impacts, environmental and other technological advances. 
 Genetically modified plants can never solve the problems related to world hunger and poverty. It is not enough 
to simply increase productivity in order to achieve a better distribution of food resources.  To effectively address the 
serious problem of food security it is a priority to improve access to land, to promote a more equitable distribution 
of wealth, strengthen the sustainability of trade agreements and reduce the volatility of commodity prices. FAO 
(Organization of the United Nations Food and Agriculture), in its most recent reports, said that the biotechnology 
does not provide significant agronomic and economic benefits to farmers within third countries, in particular small 
farmers. Since the birth of genetic engineering, however, its proponents have argued that genetically modified plants 
are indispensable to solve the problem of world hunger and fight poverty. According to predictions of the 
multinationals, plants with a high content of vitamins or other nutrients contribute to the fight against hunger and 
disease in the Third World (Monsanto, 1998). Moreover, the addition of potential characteristics such as resistance 
to drought, salinisation, frost or other " stressors " would allow the cultivation, which was not possible before, 
forecasting of an increase in yield per hectare (Monsanto, 1999). However, despite decades of promising hypothesis, 
this has not yet been commercially developed and none of these features have increased the yield. The economic 
rationale behind the development of these varieties in fact reduced, since they would be targeted at the most 
disadvantaged and deprived groups of the world's population.  
From an economic point of view, the first transgenic crops have disillusioned those who believed in them. 
Productivity of GM crops appears to be variable from crop to crop and from area to area, showing an extreme 
variability in the quality of the products obtained and yields compared to traditional crops. This variability in yields 
is verifiable for all crops, except cotton, that is the only GM plant able to increase productivity (European 
Commission, 2000). 
Although the next generation of GM will realize the promise of increasing crop yields and resistance to stress, 
that would not be enough to eradicate hunger in the world; the majority of agricultural land in developing countries 
is used to produce high-end products for export to the West. In addition, the vast majority of genetically modified 
varieties currently on the market are grown for forage and feed for livestock for meat and milk consumed in the 
Western world, (European Commission, 2000) Europe is importing 90% of soybeans to produce biofuel or plastics. 
The increase in non-food use of edible agricultural products has pushed up the prices of raw materials and foodstuffs 
on the world market, which has done nothing but exacerbate food insecurity and poverty in the world. 
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The problems of the global food supply arise not so much from production to distribution,  since global 
production is equivalent to over 150% of global consumption (Greenpeace, 2013). Consequently this requires a 
political and economic solution rather than agricultural innovation (FAO, 1999). The Committee recognizes that the 
issue of global food security will be made even more acute by the rapid increase in world population. International 
organizations such as the FAO,  major NGOs such as Oxfam, and the recent report of an authoritative group of 
experts in the framework of the UN agri International Assessment of Science and Technology to agricultural 
development (International Assessment of Agricultural Knowledge, Science and Technology for Development - 
IAASTD),  all emphasize the importance of sustainable agriculture as a solution to provide security and food self-
sufficiency. This authoritative analysis highlights the need for practical and sustainable agricultural and ecological 
techniques and not necessarily foresee a role for GMOs but rather for alternative techniques. Among these, the most 
important example cited by the IAASTD report and others, is that of marker assisted selection, which consists in the 
use of genetic markers to select certain targeted and effective features but without resorting to genetic manipulation 
or transgenic risky or unpredictable effects. This selection technique is as effective and less costly than genetic 
engineering, could be a non-controversial alternative to GMOs. Its lower cost may create fewer problems in terms of 
concentration of patents and market share. Although by no means impossible that in the future GMOs can offer 
interesting solutions, the deliberate choice to develop non-GM techniques and sustainable farming practices could 
give the EU a considerable competitive advantages, which have been lost in the context of GMOs. Investing 
intensively in sustainable agriculture, the EU can gain a leading position globally unique and innovative, with 
positive effects for the economy and jobs, innovation and competitiveness of the Union. In addition, this approach 
would be more in line with the European model of agriculture, beneficial to biodiversity, proposed in the context of 
the future CAP (Common Agricultural Policy). 
 GMOs are also considered by their proponents to be a potential tool to promote both climate change adaptation 
and mitigation of their effects. However, even in this context the current generation of genetically modified varieties 
on the market does not offer any of the features necessary for this purpose. In fact, one of the most important 
applications, namely the production of biofuels from plants in particularly food, GM already affects negatively 
world prices of raw materials and foodstuffs and their supply, while continuing to lead a strong dependence on fossil 
fuels. 
It is impossible to say with certainty that GMOs can contribute to the fight against global threats such as hunger, 
poverty, climate change and environmental issues, note that the current generation of GMOs is non- adapts for these 
purposes (Ziegler, 2010). 
That GM crops have led to a minor increased use of pesticides is scientifically questionable, and certainly rather 
than their contribution does not seem all positive. More and more research shows that the consequences they 
produce are long-term. This includes the rise of intensive monocultures, the development of pesticide resistance, 
infiltration into the groundwater and serious damage to the surrounding biodiversity as well as the risks to human 
health arising from long-term to certain pesticides used in conjunction with GMOs. Some of these effects may be 
due to poor agricultural practices however, considering that the current generation of GMOs is marketed in 
combination with the corresponding pesticides, it is necessary that these products and their impact on the 
environment and society are assessed jointly. 
6. Freedom choice 
Another important issue related to GMOs, which arises both within the Union and outside, is represented by the 
freedom of choice for consumers and farmers. In developing countries, the high prices of patented seeds, associated 
with the purchase obligation and the prohibition of the traditional practice of saving seeds from previous seasons 
create significant socio-economic and cultural dilemma among farmers, and particularly among poor and small 
farmers.  In countries where GMO cultivation is prevalent, such as USA, Canada, Argentina and Brazil the diversity 
of crops has undergone a drastic reduction.  Globally, about 80% of all soy production is genetically modified, plus 
50% of cotton and over 25% of the corn. In the EU, it is assumed that the freedom of choice for consumers and 
farmers is protected by the requirements on labelling. In order to enable consumers and farmers to continue to 
558   Margherita Arcieri /  Agriculture and Agricultural Science Procedia  8 ( 2016 )  552 – 559 
 
exercise this freedom, it is necessary to ensure a complete and reliable separation between the supply chains GM 
and non-GM production (Lappe et al. 1998). An important aspect of this separation is represented by the 
introduction of strict regulations on coexistence, including effective provisions on the liability and compensation for 
environmental damage and/or cost resulting from accidental contamination, the adoption of a certification system as 
well as requirements for purity and labelling for the presence of GM material in non-GM seed and derived products 
(Domingo-Roig and Gomez-Arnaiz, 2000). 
With regard to the revision of the procedures for assessment and risk management, as well as the authorization of 
GMOs, the Committee, the Council and the European Parliament, recommended to consult, in addition to experts in 
natural sciences, even those in the social sciences, law and ethics, as well as representatives of civil society 
organizations this consultation should ensure the inclusion, in the decision-making process, not only of the scientific 
assessment of risks to man and the environment, but also "other legitimate factors" such as socio-economic 
considerations, cultural and ethical and social values. In this way we could also help to overcome both the 
differences in society in relation to GMOs and the political gridlock that prevents you from making decisions in this 
regard. 
One of the aspects that should be addressed in any case in the future is the definition of the term GMO. Although 
the science and applications of genetic engineering have experienced a rapid development over the past decades, the 
legal definition of the term GMO has remained unchanged since the first EU legislation, adopted in 1990. According 
to the definition in effect, a GMO is a genetically modified organism and an organism, other than a human being, 
whose genetic material has been altered in a way that does not occur naturally by mating and/or natural 
recombination (Bompiani, 2000). Excluded from this definition, however, are certain techniques of genetic 
engineering, which are thus released from the legislation on GMOs. 
 However, over the years many new techniques have been developed for genetic improvement of plants that were 
not foreseen at the time when the regulatory framework currently in force was developed. It is among other 
techniques such as cisgenesis, which consists in implanting genes in an organism of the same species by the 
technique of recombinant DNA. These techniques of a new type raises the question as to what extent they fall within 
the current definition of genetic engineering and if the organisms obtained through such techniques are covered by 
the existing regulatory framework on GMOs. Given the administrative burden, but also the stigma of GMOs from 
the world of politics and public opinion, the exception to this rule is of considerable economic importance to the 
field of plant breeding. In this way, these innovations could be marketed more rapidly without the labelling 
requirement and may lead consumers to negative reactions. However, these techniques give rise to the same 
reservations which are the ethical, ecological, socio-economic and political center of the current generation because 
they essentially use the same technology of genetic engineering, for which experience is still limited and shrouded in 
considerable uncertainty. 
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